KELLY SUNSHINE: Open Payments
NPI 1740735851 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 51 payments from 15 companies in 2025. Trend: 2023 $1,532 · 2024 $1,179 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $306 |
| E.R. Squibb & Sons, L.L.C. | 4 | $188 |
| Teva Pharmaceuticals USA, Inc. | 5 | $135 |
| Almatica Pharma LLC | 4 | $96 |
| Alkermes, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| MDD US Operations, LLC | 1 | $43 |
Products named: VRAYLAR, COBENFY, AUSTEDO XR, LOREEV XR, LYBALVI, REXULTI, FANAPT, CAPLYTA.
Industry payments across FL — which companies pay providers there.
